Hypercholesterolemic aortic-valve disease [9]

New England Journal of Medicine

Volumn 349, Issue 7, 2003, Pages 717-718

  Rajamannan, Nalini M ^a   Edwards, William D ^b   Spelsberg, Thomas C ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; AORTA VALVE DISEASE; CASE REPORT; CLINICAL EXAMINATION; EVALUATION; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MALE; MICROSCOPY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; THORACIC AORTA; AORTA VALVE; ARTERIOSCLEROSIS; CHILD; FATALITY; HYPERLIPOPROTEINEMIA TYPE 2; PATHOLOGY; VALVULAR HEART DISEASE;

AORTIC VALVE; ARTERIOSCLEROSIS; CHILD; FATAL OUTCOME; HEART VALVE DISEASES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE;

EID: 0043125770     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc031360     Document Type: Letter

References (3)

1. Edwards WD. The changing spectrum of valvular heart disease pathology. In: Braunwald E, ed. Harrison's advances in cardiology. New York: McGraw-Hill, 2002:317-23.
2. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4.
3. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-7.